Amoéba S.A. Stock Price

ENXTPA:ALMIB Community·€71.8m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
4 Fair Values set on narratives written by author

Create a narrative

ALMIB Share Price Performance

€1.04

0.39 (60.06%)

€1.04

0.39 (60.06%)

€1.04

Wed, 12 Nov 25

Share Pricen/a

ALMIB Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Medium-low risk with high growth potential.

6 Risks

2 Rewards

View Full Analysis

Amoéba S.A. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.11
: -138.43%
: -1,078.96%
: -114.7%

View Full Analysis

About ALMIB

Founded: 2010
Employees: 20
CEO: Jean-Francois Doucet
WebsiteView website: amoeba-nature.com

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.